These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 11329466)

  • 1. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
    Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
    Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of cytokine response against panel of purified Mycobacterium leprae antigens by using whole blood assay in subjects residing in a resettlement village of cured leprosy patients.
    Kamble RR; Shinde VS; Madhale SP; Jadhav RS
    Indian J Lepr; 2010; 82(1):23-31. PubMed ID: 21229844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.
    Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I
    Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
    Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
    J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
    Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
    Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.